No clinical trials, no new drugs: Where is this going to lead India?

In the midst of draconian regulations and uncertainties encircling the Indian clinical trial scene, the Indian Society for Clinical Research (ISCR), a body which primarily represents the interest of all stakeholders in the clinical research, organized a press meet on January 9, 2014, as a kick-starter for its two-day 7th annual conference themed, ‘Clinical Research at Crossroads', happening from January 10-11, 2014, at The Lalit Ashok, in Bangalore.

Eminent academician and clinical pharmacologist Padmashree Prof Ranjit Roy Chaudhury will be the guest of honor at the two-day conference along with distinguished clinical research professionals who will discuss the recent developments in clinical research across the globe, and create a forum to help clinical research professionals to appreciate what is happening in India and take some of the best practices and implement them in the country.

India has about 16% of the world's population and 20% of the global disease burden. However, only less than 1.5% of global trials take place in the country.

Ms Suneela Thatte, president, ISCR, who was at the press meet said that the media is an important stakeholder in this regard, and that it should send across the right message about clinical trials, which has the ability to bring new medicines to meet unmet medical needs.

She said, "Media brings an important role in bringing about awareness about clinical trials and patient rights, ensuring the voice of clinical researchers and stakeholders are heard by policy makers."


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email